This Canada-UK collaborative project aims to establish large-scale, GMP (Good Manufacturing Practices)-compliant manufacturing of bacteriophages to combat antimicrobial-resistant infections. Using an innovative bioreactor, the team will scale up production for several phage candidates targeting WHO-priority pathogens. The project integrates innovative technologies for phage characterization and rapid diagnostic testing.
This record is a historical disbursement from Canada's open grants database — it documents a past payment, not an active program accepting applications.
View disbursement record →